Page last updated: 2024-08-21

trinitrobenzenesulfonic acid and Colorectal Neoplasms

trinitrobenzenesulfonic acid has been researched along with Colorectal Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beck, SE; Chan, GV; Chan, JL; Chung, L; Ding, H; Fan, H; Geis, AL; Gomes, TAM; Housseau, F; Pardoll, DM; Sears, CL; Tam, AJ; Wang, H; Wu, S; Wu, X1
Bernier, SG; Bryant, AP; Bueno, L; Currie, MG; Eutamene, H; Ge, P; Graul, C; Hannig, G; Jacobson, S; Jin, H; Kessler, MM; Kurtz, CB; Liong, E; Pezzone, MA; Reza, T; Rivers, S; Shea, C; Silos-Santiago, I; Tchernychev, B; Ustinova, EE1
Arber, N; Brazowski, E; Elinav, E; Hart, G; Maharshak, N; Margalit, R; Ron, E; Sagiv, A; Shachar, I; Zelman, E1
Bak, AW; Devchand, PR; Wallace, JL; Zamuner, SR1

Other Studies

4 other study(ies) available for trinitrobenzenesulfonic acid and Colorectal Neoplasms

ArticleYear
Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A.
    Mucosal immunology, 2019, Volume: 12, Issue:1

    Topics: Adenomatous Polyposis Coli Protein; Animals; Bacteroides fragilis; Carcinogenesis; Cells, Cultured; Colitis; Colorectal Neoplasms; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Interleukin-17; Intestinal Mucosa; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Th17 Cells; Trinitrobenzenesulfonic Acid

2019
Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation.
    Pain, 2013, Volume: 154, Issue:9

    Topics: Acetylcholine; Acetylglucosamine; Adenocarcinoma; Animals; Cell Differentiation; Cell Line, Tumor; Colitis; Colon; Colorectal Neoplasms; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Female; Gastrointestinal Diseases; Gene Expression Regulation, Neoplastic; Guanylate Cyclase; Humans; Hyperalgesia; Intestinal Mucosa; Male; Mast Cells; Morphine; Multidrug Resistance-Associated Proteins; Natriuretic Peptides; Organic Anion Transporters, Sodium-Independent; Peroxidase; Rats; Rats, Sprague-Dawley; Rats, Wistar; Restraint, Physical; RNA, Messenger; Signal Transduction; Trinitrobenzenesulfonic Acid; Visceral Pain

2013
CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:9

    Topics: Animals; Azoxymethane; Blotting, Western; Carcinogens; Cell Adhesion; Cell Movement; Cell Proliferation; Chemokine CCL2; Colitis; Colon; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Immunoenzyme Techniques; Inflammatory Bowel Diseases; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Trinitrobenzenesulfonic Acid

2010
Predisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2-derived prostaglandin d2.
    The American journal of pathology, 2005, Volume: 167, Issue:5

    Topics: Animals; Azoxymethane; beta Catenin; Colitis; Colon; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Disease Susceptibility; Intramolecular Oxidoreductases; Lipocalins; Male; Prostaglandin D2; Rats; Rats, Wistar; Receptors, Immunologic; Receptors, Prostaglandin; Trinitrobenzenesulfonic Acid

2005